Bioconjugation of Captopril–Light Subunit of Agaricus bisporus Mushroom Tyrosinase: Characterization and Potential Use as a Drug Carrier for Oral Delivery

Diana, . and Ismaya, Wangsa Tirta and Meidianto, Vincentius Felix and Tandrasasmita, Olivia Mayasari and Tjandrawinata, Raymond Rubianto and Rachmawati, Heni (2018) Bioconjugation of Captopril–Light Subunit of Agaricus bisporus Mushroom Tyrosinase: Characterization and Potential Use as a Drug Carrier for Oral Delivery. Biological and Pharmaceutical Bulletin, 41 (12). pp. 1837-1842. ISSN Online ISSN: 1347-5215 P-ISSN: 0918-6158 ISSN-L: 0918-6158, Jurnal Internasional Bereputasi Q2, SJR 0.56

[img]
Preview
Text (Bioconjugation of Captopril–Light Subunit of Agaricus bisporus Mushroom Tyrosinase: Characterization and Potential Use as a Drug Carrier for Oral Delivery)
1-Bioconjugation_of_captopril_.pdf

Download (1MB) | Preview
[img]
Preview
Text (Bioconjugation of Captopril–Light Subunit of Agaricus bisporus Mushroom Tyrosinase: Characterization and Potential Use as a Drug Carrier for Oral Delivery_peer_review)
1-R1&2-Bioconjugation_.pdf

Download (1MB) | Preview
[img]
Preview
Text (Bioconjugation of Captopril–Light Subunit of Agaricus bisporus Mushroom Tyrosinase: Characterization and Potential Use as a Drug Carrier for Oral Delivery)
1-Bioconjugation_of_captopril_Hasil Cek Similaity.pdf

Download (3MB) | Preview

Abstract

We show that a lectin like protein from the mushroom Agaricus bisporus (LSMT) is capable to permeate the epithelial monolayer barrier of the intestine ex vivo. The protein is not toxic or immunogenic upon prolonged administration and elevated dose in mice. Thus, it could be a candidate as a drug carrier for oral administration. However, its permeability should be tested after the protein has been modified, mimicking the condition in which it is used as a drug carrier. The protein was conjugated to captopril, the selected model of a Biopharmaceutical Classification System (BCS) class III drug, with high solubility but poor permeability. The drug was conjugated to LSMT that had been modified with 4-succinimidyloxycarbonyl-alpha-methyl- 2-pyridyldithiotoluene (SMPT) as a linker. The success of LSMT modification was confirmed with TLC and MS; the latter also indicated the amount of captopril molecule linked. The modified LSMT could permeate through the intestinal monolayer barrier, and thus could be absorbed in the intestine after modification. The modified protein appears to remain stable after incubation in simulated gastrointestinal fluids. This pioneering work provides an essential basis for further development of the protein as a drug carrier for oral administration.

Item Type: Article
Additional Information: Jurnal Internasional Bereputasi Q2, SJR 0.56
Uncontrolled Keywords: light subunit mushroom tyrosinase; protein conjugation; orf239342; novel protein-based drugcarrier; mushroom tyrosinase associated lectin-like protein
Subjects: Pharmacy
Divisions: Journal Publication
Depositing User: F.X. Hadi
Date Deposited: 07 Aug 2019 02:12
Last Modified: 11 Oct 2019 06:40
URI: http://repository.wima.ac.id/id/eprint/19810

Actions (login required)

View Item View Item